1. Home
  2. AMTX vs NVNO Comparison

AMTX vs NVNO Comparison

Compare AMTX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMTX
  • NVNO
  • Stock Information
  • Founded
  • AMTX 2005
  • NVNO 1987
  • Country
  • AMTX United States
  • NVNO United States
  • Employees
  • AMTX N/A
  • NVNO N/A
  • Industry
  • AMTX Major Chemicals
  • NVNO Medical/Dental Instruments
  • Sector
  • AMTX Industrials
  • NVNO Health Care
  • Exchange
  • AMTX Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • AMTX 96.3M
  • NVNO 78.7M
  • IPO Year
  • AMTX N/A
  • NVNO N/A
  • Fundamental
  • Price
  • AMTX $2.19
  • NVNO $4.05
  • Analyst Decision
  • AMTX Strong Buy
  • NVNO
  • Analyst Count
  • AMTX 4
  • NVNO 0
  • Target Price
  • AMTX $13.43
  • NVNO N/A
  • AVG Volume (30 Days)
  • AMTX 934.3K
  • NVNO 135.7K
  • Earning Date
  • AMTX 07-31-2025
  • NVNO 07-30-2025
  • Dividend Yield
  • AMTX N/A
  • NVNO N/A
  • EPS Growth
  • AMTX N/A
  • NVNO N/A
  • EPS
  • AMTX N/A
  • NVNO N/A
  • Revenue
  • AMTX $237,892,000.00
  • NVNO N/A
  • Revenue This Year
  • AMTX $27.78
  • NVNO N/A
  • Revenue Next Year
  • AMTX $91.59
  • NVNO $409.09
  • P/E Ratio
  • AMTX N/A
  • NVNO N/A
  • Revenue Growth
  • AMTX N/A
  • NVNO N/A
  • 52 Week Low
  • AMTX $1.22
  • NVNO $2.03
  • 52 Week High
  • AMTX $4.73
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • AMTX 65.90
  • NVNO 54.46
  • Support Level
  • AMTX $2.11
  • NVNO $4.19
  • Resistance Level
  • AMTX $2.39
  • NVNO $4.52
  • Average True Range (ATR)
  • AMTX 0.14
  • NVNO 0.39
  • MACD
  • AMTX 0.03
  • NVNO -0.01
  • Stochastic Oscillator
  • AMTX 66.03
  • NVNO 47.29

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: